Literature DB >> 23475824

Catechol-O-methyltransferase gene val158met polymorphism and depressive symptoms during early childhood.

Haroon I Sheikh1, Katie R Kryski, Heather J Smith, Lea R Dougherty, Daniel N Klein, Sara J Bufferd, Shiva M Singh, Elizabeth P Hayden.   

Abstract

Catechol-O-Methyltransferase (COMT) is a critical regulator of catecholamine levels in the brain. A functional polymorphism of the COMT gene, val158met, has been linked to internalizing symptoms (i.e., depression and anxiety) in adolescents and adults. We extended this research by investigating whether the val158met polymorphism was associated with childhood symptoms of depression and anxiety in two independent samples of young children (Ns = 476 and 409). In both samples, preschool-aged children were genotyped for the COMT val158met polymorphism. Symptoms of psychopathology were assessed via parent interviews and primary caregiver reports. In both samples, children homozygous for the val allele had higher levels of depressive symptoms compared to children with at least one copy of the met allele. Our findings extend previous research in older participants by showing links between the COMT val158met polymorphism and internalizing symptoms in early childhood.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475824      PMCID: PMC5288403          DOI: 10.1002/ajmg.b.32141

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  69 in total

Review 1.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

2.  Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.

Authors:  M Karayiorgou; C Sobin; M L Blundell; B L Galke; L Malinova; P Goldberg; J Ott; J A Gogos
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

3.  Test-Retest Reliability of the Preschool Age Psychiatric Assessment (PAPA).

Authors:  Helen Link Egger; Alaattin Erkanli; Gordon Keeler; Edward Potts; Barbara Keith Walter; Adrian Angold
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-05       Impact factor: 8.829

Review 4.  Cognition and depression: current status and future directions.

Authors:  Ian H Gotlib; Jutta Joormann
Journal:  Annu Rev Clin Psychol       Date:  2010       Impact factor: 18.561

5.  Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study.

Authors:  I Massat; D Souery; J Del-Favero; M Nothen; D Blackwood; W Muir; R Kaneva; A Serretti; C Lorenzi; M Rietschel; V Milanova; G N Papadimitriou; D Dikeos; C Van Broekhoven; J Mendlewicz
Journal:  Mol Psychiatry       Date:  2005-06       Impact factor: 15.992

6.  Mental health, educational, and social role outcomes of adolescents with depression.

Authors:  David M Fergusson; Lianne J Woodward
Journal:  Arch Gen Psychiatry       Date:  2002-03

7.  Association study of candidate variants of COMT with neuroticism, anxiety and depression.

Authors:  Naomi R Wray; Michael R James; Troy Dumenil; Herlina Y Handoko; Penelope A Lind; Grant W Montgomery; Nicholas G Martin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-10-05       Impact factor: 3.568

Review 8.  Assessing the molecular genetics of the development of executive attention in children: focus on genetic pathways related to the anterior cingulate cortex and dopamine.

Authors:  K Brocki; S M Clerkin; K G Guise; Jin Fan; J A Fossella
Journal:  Neuroscience       Date:  2009-01-20       Impact factor: 3.590

9.  Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.

Authors:  Claudia Rothe; Diana Koszycki; Jacques Bradwejn; Nicole King; Vincenzo Deluca; Subi Tharmalingam; Fabio Macciardi; Jürgen Deckert; James L Kennedy
Journal:  Neuropsychopharmacology       Date:  2006-03-08       Impact factor: 7.853

10.  Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity.

Authors:  Katharina Domschke; Juergen Deckert; Michael C O'donovan; Stephen J Glatt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-07-05       Impact factor: 3.568

View more
  4 in total

1.  Neonatal pain and COMT Val158Met genotype in relation to serotonin transporter (SLC6A4) promoter methylation in very preterm children at school age.

Authors:  Cecil M Y Chau; Manon Ranger; Dian Sulistyoningrum; Angela M Devlin; Tim F Oberlander; Ruth E Grunau
Journal:  Front Behav Neurosci       Date:  2014-12-02       Impact factor: 3.558

2.  Effects of Antenatal Maternal Depressive Symptoms and Socio-Economic Status on Neonatal Brain Development are Modulated by Genetic Risk.

Authors:  Anqi Qiu; Mojun Shen; Claudia Buss; Yap-Seng Chong; Kenneth Kwek; Seang-Mei Saw; Peter D Gluckman; Pathik D Wadhwa; Sonja Entringer; Martin Styner; Neerja Karnani; Christine M Heim; Kieran J O'Donnell; Joanna D Holbrook; Marielle V Fortier; Michael J Meaney
Journal:  Cereb Cortex       Date:  2017-05-01       Impact factor: 5.357

3.  Association between COMT polymorphism, labor anxiety, and analgesia in pregnant women.

Authors:  Xiaohui Ren; Le Zhang; Qiuxia Xiao; Daxue Huang; Qing Liu; Ying Zhang
Journal:  J Pain Res       Date:  2019-02-27       Impact factor: 3.133

4.  Comparative study of the efficacy of dexmedetomidine and fentanyl on anxiety and pain of parturients with different COMTva1158met genotypes.

Authors:  Li-Jia Tang; Jiang Han; Yi-Juan Feng; Cui-Xia Pu; Ying Zhang
Journal:  BMC Anesthesiol       Date:  2022-03-28       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.